Your session is about to expire
← Back to Search
Shorter-lasting vs Standard Radiation for Prostate Cancer
Study Summary
This trial is testing whether a shorter-lasting radiation treatment will be more effective at treating prostate cancer. 660 patients will be randomly assigned to either the shorter-lasting treatment or the standard treatment.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Media Library
- My prostate cancer has a low Gleason score.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do I fit the criteria to partake in this research?
"Prostate cancer patients that are between 40 and 90 years old may be eligible for this 660-person clinical trial."
Are there any risks associated with this treatment?
"This intervention has undergone Phase 3 clinical trials, which is the last stage before FDA approval. This means that there is data supporting both its efficacy and safety, so it received a score of 3."
Are elderly patients above the age of 70 able to participate in this particular experiment?
"The age requirements to participate in this trial are between 40-90 years old."
Are there any unfilled roles in this research project?
"Unfortunately, this particular clinical trial is no longer recruiting patients. This is according to the most recent update on clinicaltrials.gov which was from June 12th, 2007. Although, there are 1,364 other studies that are currently enrolling participants."
Share this study with friends
Copy Link
Messenger